EE665 Evaluation of Resource Use and Costs of Pertuzumab and Trastuzumab Formulations in HER2- Positive Breast Cancer
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.930
https://www.valueinhealthjournal.com/article/S1098-3015(23)04060-3/fulltext
Title :
EE665 Evaluation of Resource Use and Costs of Pertuzumab and Trastuzumab Formulations in HER2- Positive Breast Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04060-3&doi=10.1016/j.jval.2023.09.930
First page :
Section Title :
Open access? :
No
Section Order :
10423